PL148757B1 - Method of obtaining derivatives of methylenedioxyphenatrene - Google Patents
Method of obtaining derivatives of methylenedioxyphenatrene Download PDFInfo
- Publication number
- PL148757B1 PL148757B1 PL1986261196A PL26119686A PL148757B1 PL 148757 B1 PL148757 B1 PL 148757B1 PL 1986261196 A PL1986261196 A PL 1986261196A PL 26119686 A PL26119686 A PL 26119686A PL 148757 B1 PL148757 B1 PL 148757B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- histiocytes
- red blood
- blood cells
- itn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853530718 DE3530718A1 (de) | 1985-08-28 | 1985-08-28 | Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL261196A1 PL261196A1 (en) | 1988-02-04 |
| PL148757B1 true PL148757B1 (en) | 1989-11-30 |
Family
ID=6279566
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1986261196A PL148757B1 (en) | 1985-08-28 | 1986-08-27 | Method of obtaining derivatives of methylenedioxyphenatrene |
| PL1986268178A PL154026B1 (en) | 1985-08-28 | 1986-08-27 | Method of obtaining derivativies of methylene dioxyphenanthrene |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1986268178A PL154026B1 (en) | 1985-08-28 | 1986-08-27 | Method of obtaining derivativies of methylene dioxyphenanthrene |
Country Status (27)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE432983T1 (de) * | 1989-12-15 | 1992-03-19 | Pharma Mar, S.A., Madrid | Neue verbindungen des diterpentyps. |
| ATE116637T1 (de) * | 1991-02-05 | 1995-01-15 | Merrell Dow Pharma | Sulfonische stilbenderivate zur behandlung von viruserkrankungen. |
| EP0626945B1 (en) * | 1992-02-20 | 1998-04-22 | Merrell Pharmaceuticals Inc. | Sulfonic acid derivatives in the treatment of viral diseases |
| US5334615A (en) * | 1992-12-17 | 1994-08-02 | Walles Wilhelm E | Oil with bactericidal and virucidal properties |
| US5739166A (en) * | 1994-11-29 | 1998-04-14 | G.D. Searle & Co. | Substituted terphenyl compounds for the treatment of inflammation |
| CN112778264B (zh) * | 2021-01-21 | 2023-09-15 | 江西农业大学 | 马兜铃次酸衍生物及其在制备抗炎药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4122092A (en) * | 1977-08-25 | 1978-10-24 | University Of Rochester | Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone |
| JPS57106677A (en) * | 1980-12-22 | 1982-07-02 | Kureha Chem Ind Co Ltd | N-(3,4-methylenedioxybenzylidene) aminomethylcyclohexane-carboxylic acid, and salt of said carboxylic acid |
-
1985
- 1985-08-28 DE DE19853530718 patent/DE3530718A1/de active Granted
-
1986
- 1986-08-08 AT AT0215186A patent/AT398568B/de not_active IP Right Cessation
- 1986-08-12 GB GB8619644A patent/GB2179347B/en not_active Expired
- 1986-08-13 FI FI863282A patent/FI92396C/fi not_active IP Right Cessation
- 1986-08-20 AR AR86304988A patent/AR242568A1/es active
- 1986-08-20 LU LU86556A patent/LU86556A1/de unknown
- 1986-08-21 NL NL8602127A patent/NL8602127A/nl not_active Application Discontinuation
- 1986-08-22 YU YU1475/86A patent/YU44061B/xx unknown
- 1986-08-25 CH CH3406/86A patent/CH673457A5/de not_active IP Right Cessation
- 1986-08-26 SE SE8603589A patent/SE465153B/sv not_active IP Right Cessation
- 1986-08-26 IT IT8621526A patent/IT1197467B/it active
- 1986-08-26 MX MX003550A patent/MX172917B/es unknown
- 1986-08-27 PT PT83258A patent/PT83258B/pt not_active IP Right Cessation
- 1986-08-27 SU SU864028078A patent/SU1731053A3/ru active
- 1986-08-27 FR FR868612129A patent/FR2586681B1/fr not_active Expired - Fee Related
- 1986-08-27 PL PL1986261196A patent/PL148757B1/pl unknown
- 1986-08-27 HU HU895304A patent/HU202104B/hu not_active IP Right Cessation
- 1986-08-27 ES ES8601409A patent/ES2001893A6/es not_active Expired
- 1986-08-27 BE BE0/217092A patent/BE905340A/fr not_active IP Right Cessation
- 1986-08-27 DK DK407586A patent/DK168705B1/da not_active IP Right Cessation
- 1986-08-27 PL PL1986268178A patent/PL154026B1/pl unknown
- 1986-08-27 HU HU863711A patent/HU199446B/hu not_active IP Right Cessation
- 1986-08-27 DD DD86293892A patent/DD266800A5/de not_active IP Right Cessation
- 1986-08-27 ZA ZA866487A patent/ZA866487B/xx unknown
- 1986-08-27 IE IE228886A patent/IE59239B1/en not_active IP Right Cessation
- 1986-08-27 NO NO863434A patent/NO863434L/no unknown
- 1986-08-27 HU HU895304A patent/HU895304D0/hu not_active IP Right Cessation
- 1986-08-28 JP JP61200261A patent/JPS62167776A/ja active Granted
- 1986-08-28 KR KR1019860007146A patent/KR880000179B1/ko not_active Expired
-
1987
- 1987-06-19 YU YU1149/87A patent/YU43998B/xx unknown
-
1988
- 1988-03-22 US US07/171,695 patent/US4835178A/en not_active Expired - Fee Related
-
1989
- 1989-12-27 US US07/457,353 patent/US5024743A/en not_active Expired - Fee Related
-
1993
- 1993-01-27 MX MX9300436A patent/MX9300436A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lieske et al. | Adhesion, internalization and metabolism of calcium oxalate monohydrate crystals by renal epithelial cells | |
| PL148757B1 (en) | Method of obtaining derivatives of methylenedioxyphenatrene | |
| UA62967C2 (en) | Peptide analogs of parathyroid hormons | |
| CA2276738A1 (en) | Vitronectin receptor antagonists | |
| CA3061363A1 (en) | Propionic acid derivatives and methods of use thereof | |
| Swierenga et al. | Alteration by malignant transformation of the calcium requirements for cell proliferation in vitro | |
| EA002271B1 (ru) | ТРИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ, ОБЛАДАЮЩИЕ АКТИВНОСТЬЮ В ОТНОШЕНИИ ИНТЕГРИНОВ, В ЧАСТНОСТИ В ОТНОШЕНИИ ИНТЕГРИНА АЛЬФАvБЕТА 3, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, ИСПОЛЬЗУЕМЫЕ В ЭТОМ СПОСОБЕ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МЕДИКАМЕНТОВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| CA2359660A1 (en) | 16-hydroxyestratrienes as selective estrogens | |
| CN103097392B (zh) | 具有2,5,7-取代的噁唑并嘧啶环的羧酸衍生物 | |
| OA11724A (en) | Vitronectin receptor antagonist. | |
| EP1005347A1 (en) | Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases | |
| CA2416537A1 (en) | Calcilytic compounds | |
| Mao et al. | Topological cues of microparticles train stem cells for tissue repair via mechanotransduction | |
| TW201111328A (en) | Novel uses | |
| Chan et al. | Characterisation and uptake of paraquat by rat renal proximal tubular cells in primary culture | |
| JPH09500371A (ja) | トロンビンレセプター放射性リガンド及びトロンビンレセプターアンタゴニスト同定アッセイ | |
| NO174808B (no) | Fremgangsmåte for fremstilling av terapeutisk aktive metylendioksyfenantren-derivater | |
| NO175635B (cg-RX-API-DMAC10.html) | ||
| CN114276402B (zh) | 一种甾体衍生物及其在制备抗肿瘤药物中的应用 | |
| DK144564B (da) | Analogifremgangsmaade til fremstilling af symmetriske methylsubstituerede 3,14-dithia-1,16-hexadecandioler | |
| WO2023049727A1 (en) | Virucidal compositions and use thereof | |
| KR20150133317A (ko) | 간엽세포 및 상피세포 혼합물에서 간엽세포 혹은 상피세포의 분리방법 | |
| US3009923A (en) | Process for the preparation of alpha-lglutamyl-choline and its salts | |
| Hennemann et al. | XENOPUS LAEVIS OOCYTES | |
| JPS58225017A (ja) | 脱ガン剤 |